Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
581,867
+34,387
+6% +$665K ﹤0.01% 1855
2025
Q4
$8.96M Sell
547,480
-1,328,509
-71% -$23.4M ﹤0.01% 1999
2025
Q3
$35.3M Sell
1,875,989
-295,889
-14% -$5.31M 0.01% 1068
2025
Q2
$43.9M Buy
2,171,878
+592,212
+37% +$10.2M 0.01% 930
2025
Q1
$21.7M Buy
1,579,666
+249,767
+19% +$3.44M 0.01% 1257
2024
Q4
$15.7M Buy
1,329,899
+110,948
+9% +$1.75M ﹤0.01% 1495
2024
Q3
$21.4M Buy
1,218,951
+22,431
+2% +$409K 0.01% 1295
2024
Q2
$21M Buy
1,196,520
+181,286
+18% +$3.75M 0.01% 1249
2024
Q1
$26M Buy
1,015,234
+30,672
+3% +$769K 0.01% 1145
2023
Q4
$25.7M Buy
984,562
+960,164
+3,935% +$21.9M 0.01% 1115
2023
Q3
$563K Buy
24,398
+607
+3% +$15.2K ﹤0.01% 3359
2023
Q2
$558K Sell
23,791
-20,495
-46% -$348K ﹤0.01% 3395
2023
Q1
$526K Sell
44,286
-884,066
-95% -$12.6M ﹤0.01% 3416
2022
Q4
$14.2M Sell
928,352
-1,302,980
-58% -$22.8M ﹤0.01% 1448
2022
Q3
$42.4M Sell
2,231,332
-25,244
-1% -$501K 0.02% 763
2022
Q2
$40.5M Buy
2,256,576
+122,159
+6% +$2.81M 0.01% 813
2022
Q1
$64.2M Buy
2,134,417
+164,705
+8% +$5.14M 0.02% 692
2021
Q4
$56.6M Buy
1,969,712
+211,065
+12% +$6.87M 0.02% 784
2021
Q3
$70.6M Buy
1,758,647
+45,763
+3% +$2.04M 0.02% 625
2021
Q2
$74.6M Buy
1,712,884
+68,898
+4% +$2.85M 0.02% 630
2021
Q1
$61.9M Buy
1,643,986
+13,133
+0.8% +$561K 0.02% 687
2020
Q4
$64.7M Buy
1,630,853
+531,036
+48% +$21.7M 0.02% 630
2020
Q3
$45.8M Buy
1,099,817
+292,759
+36% +$13.4M 0.02% 679
2020
Q2
$33.9M Sell
807,058
-803,335
-50% -$24.6M 0.01% 773
2020
Q1
$31M Sell
1,610,393
-883,741
-35% -$29.9M 0.02% 725
2019
Q4
$95.9M Buy
+2,494,134
New +$93.6M 0.04% 430

Other funds holding XP

Ameriprise's XP Position: Q1 2026 in Review

Ameriprise increased its XP (XP) stake by 6.3% in Q1 2026, buying an estimated $665K and bringing the position to 581,867 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.

Ameriprise first reported a position in XP in Q4 2019 and has held it in 26 quarters since. The position peaked at $95.9M in Q4 2019. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • Ameriprise held 581,867 shares of XP worth $11.1M as of Q1 2026.
  • Ameriprise bought 34,387 XP shares in Q1 2026, an estimated $665K.
  • XP made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1855 holding.
  • Ameriprise first reported a position in XP in Q4 2019 and has held it in 26 quarters since.
  • Ameriprise's XP position peaked at $95.9M in Q4 2019.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.